C. Lamers

发表

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.

P. Quax, C. V. D. van de Velde, S. Ganesh, 1994, Gastroenterology.

Flexible Limited Sampling Model for Monitoring Tacrolimus in Stable Patients Having Undergone Liver Transplantation With Samples 4 to 6 Hours After Dosing Is Superior to Trough Concentration

D. Hommes, C. Lamers, J. Hartigh, 2008, Therapeutic drug monitoring.

Switching monitoring of emulsified cyclosporine from trough level to 2‐hour level in stable liver transplant patients

J. Ringers, C. Lamers, B. van Hoek, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Author affiliations

Ron Wolterbeek, Daniel W. Hommes, J. Ringers, 2011, Canadian Medical Association Journal.

MMP-2 and MMP-9 Serum Levels Change but their Gene Promoter Polymorphisms are not Associated with Late Phase I/R Injury or Rejection after Orthotopic Liver Transplantation

D. Hommes, H. Verspaget, C. Lamers, 2008 .

Tetranectin expression in human colonic neoplasia

H. Verspaget, I. Clemmensen, S. Ganesh, 1994, Histopathology.

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.

P. Quax, H. Verspaget, Cornelis F. M. Sier, 1991, Gastroenterology.

Plasminogen Activators and Gastrointestinal Neoplasms

H. Verspaget, G. Griffioen, J. Verheijen, 1989 .

Characteristics of diarrhoea in 10 008 users of lansoprazole in daily practice: which co‐factors contribute?

H. Leufkens, E. Heerdink, C. Lamers, 2002, Pharmacoepidemiology and drug safety.

Solitary and synchronous adenomas of the colon and rectum: comparison of malignancy parameters

H. Verspaget, F. Bosman, G. Griffioen, 1990, Histopathology.

The expression of carcinoembryonic antigen and secretory component in adenomas of the human colon and rectum

H. Verspaget, F. Bosman, G. Griffioen, 1989, Diseases of the colon and rectum.

Plasminogen activator profiles in neoplastic tissues of the human colon.

H. Verspaget, G. Griffioen, J. Verheijen, 1988, Cancer research.

Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease

H. Verspaget, G. Griffioen, C. Lamers, 1994, Journal of gastroenterology and hepatology.

The Serological Gastric Biopsy: a Non-Endoscopical Diagnostic Approach in Management of the Dyspeptic Patient Significance for Primary Care Based on a Survey of the Literature

C. Lamers, I. Biemond, A. Korstanje, 2002, Scandinavian journal of gastroenterology. Supplement.

Suppression of intestinal mucosal natural killer cells by corticosteroids

H. Verspaget, G. Griffioen, C. Lamers, 1997, Alimentary pharmacology & therapeutics.

Familial adenomatous polyposis: from bedside to bench and vice versa

H. Verspaget, G. Griffioen, C. Lamers, 1999, Cytogenetic and Genome Research.

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

H. Verspaget, S. Ganesh, F. Kubben, 1996, British Journal of Cancer.

The value of screening and central registration of families with familial adenomatous polyposis

G. Griffioen, C. Lamers, H. Vasen, 1990, Diseases of the colon and rectum.

A prospective follow‐up study of 5669 users of lansoprazole in daily practice

H. Leufkens, E. Heerdink, C. Lamers, 1997, Alimentary pharmacology & therapeutics.

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

C. V. D. van de Velde, S. Ganesh, Cornelis F. M. Sier, 1994, Cancer research.

Malignancies in Inflammatory Bowel Disease: Fact or Fiction?

C. Lamers, R. Veenendaal, R. V. Hogezand, 2002, Scandinavian journal of gastroenterology. Supplement.

Comparison Between Serology and Histology in the Diagnosis of Advanced Gastric Body Atrophy: A Study in a Dutch Primary Community

C. Lamers, J. Offerhaus, J. Souverijn, 2008, Journal of clinical gastroenterology.

Role of matrix metalloproteinase,tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease

D. Hommes, H. Verspaget, C. Lamers, 2007 .

Carcinoid Heart Disease: an Update

C. Lamers, B. Taal, P. Quaedvlieg, 2002, Scandinavian journal of gastroenterology. Supplement.

Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors.

H. Verspaget, C. Lamers, L. Hawinkels, 2011, World journal of gastroenterology.

Chapter 5 Interaction between colon cancer cells and fibroblasts generates myofibroblasts via activation of Transforming Growth Factor-1

D. Hommes, H. Verspaget, P. Dijke, 2009 .

5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.

D. Hommes, H. Verspaget, C. Lamers, 2010, Cancer letters.

Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

O. Visser, C. Lamers, B. Taal, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

M. V. van Velthuysen, C. Lamers, B. Taal, 2002, Human pathology.

Active TGF‐β1 correlates with myofibroblasts and malignancy in the colorectal adenoma‐carcinoma sequence

D. Hommes, H. Verspaget, Cornelis F. M. Sier, 2009 .

Chapter 4 Active TGF-1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence

D. Hommes, H. Verspaget, J. Verheijen, 2009 .

Pancreatic Carcinoma in Carriers of a Specific 19 Base Pair Deletion of CDKN 2 A / p 16 ( p 16-Leiden ) 1

H. Morreau, N. Gruis, W. Bergman, 2003 .

Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer.

N. Muñoz, C. Lamers, P. Correa, 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease

H. Verspaget, C. Lamers, I. Biemond, 1998, Digestive Diseases and Sciences.

Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.

J. Vandenbroucke, C. Lamers, R. Schlemper, 1995, Gut.

Effects of indomethacin on intragastric pH and meal‐stimulated serum gastrin secretion in rheumatoid arthritis patients

B. Dijkmans, J. Vandenbroucke, C. Lamers, 1993, Alimentary pharmacology & therapeutics.

H. Verspaget, G. Griffioen, C. Lamers, 1990, Free radical biology & medicine.

Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community

C. Lamers, J. Souverijn, F. Roelandse, 2006, European journal of gastroenterology & hepatology.

Dyspepsia and Helicobacter pylori in Japanese employees with and without ulcer history

C. Lamers, R. Schlemper, I. Biemond, 1995, Journal of gastroenterology and hepatology.

Gastric mucosal plasminogen activators inHelicobacter pylori infection

Y. Vergouwe, H. Verspaget, C. Lamers, 1996, Digestive Diseases and Sciences.

Gastric mucosal superoxide dismutases in Helicobacter pylori infection.

H. Verspaget, C. Lamers, I. Biemond, 1996, Gut.

The effect of treatment of Helicobacter pylori infection on gastric mucosal plasminogen activators

H. Verspaget, C. Lamers, R. Veenendaal, 1996 .

Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.

H. Verspaget, D. Taylor, C. Lamers, 1997, Scandinavian journal of gastroenterology.

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

C. V. D. van de Velde, H. Verspaget, S. Ganesh, 1996, Cancer.

Eradication of Helicobacter pylori Infection Favourably Affects Altered Gastric Mucosal MMP‐9 Levels

H. Verspaget, M. Schram, F. Kubben, 2007, Helicobacter.

CHAPTER 3 Eradication of Helicobacter pylori infection favourably a ects altered gastric mucosal MMP-9 levels

H. Verspaget, M. Schram, F. Kubben, 2007 .

Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer.

C. Bosman, C. V. D. van de Velde, H. Verspaget, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.

H. Verspaget, C. Lamers, R. Veenendaal, 1997, Gut.

Epithelial Cell Proliferative Activity of Barrett's Esophagus (Methodology and Correlation with Traditional Cancer Risk Markers)

E. Kuipers, J. Koudstaal, A. Karrenbeld, 1998, Digestive Diseases and Sciences.

Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus.

E. Kuipers, A. Karrenbeld, J. Kleibeuker, 1997, Scandinavian journal of gastroenterology.

An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.

H. Verspaget, C. Lamers, I. Biemond, 2011, The Netherlands journal of medicine.

Chapter 2 Expression of Matrix Metalloproteinases-2 and-9 in Intestinal Tissue of Patients with Inflammatory Bowel Disease ( IBD ) Short title : gelatinases in IBD

H. Verspaget, Q. Gao, F. Kubben, 2009 .

Chapter 6 Expression of matrix metalloproteinases ( M M P )-2 and M M P-9 in intestinal tissue of patients with inflammatory bowel diseases ( IBD ) Short title : MMPs in IBD

H. Verspaget, Q. Gao, F. Kubben, 2005 .

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.

H. Verspaget, M. Meijer, Q. Gao, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease

H. Verspaget, C. Lamers, L. Kruidenier, 2003, The Journal of pathology.

5‐aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes

D. Hommes, H. Verspaget, C. Lamers, 2010, Inflammatory bowel diseases.

Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

H. Verspaget, C. Lamers, A. Peña, 1991, Gut.

Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review.

H. Verspaget, C. Lamers, A. Peña, 1991, Scandinavian journal of gastroenterology. Supplement.

Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold.

B. Dijkmans, J. Vandenbroucke, C. Lamers, 1992, Annals of the rheumatic diseases.

Visualization and characterization of CCK receptors in exocrine pancreas of rat with storage phosphor autoradiography.

C. Lamers, I. Biemond, C. Tang, 1996, Pancreas.

Effect of intragastric or intraduodenal administration of a polymeric diet on gallbladder motility, small-bowel transit time, and hormone release

A. Masclee, C. Lamers, I. Biemond, 1998, American Journal of Gastroenterology.

Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long‐term treatment with omeprazole

C. Lamers, I. Biemond, I. J. Kuijpers, 1994, Alimentary pharmacology & therapeutics.

Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice.

H. Verspaget, F. Zijlstra, D. Jaarsma, 2003, Free radical biology & medicine.

Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease

H. Verspaget, S. Marklund, C. Lamers, 2003, The Journal of pathology.

Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan.

J. Vandenbroucke, C. Lamers, R. Schlemper, 1993, Scandinavian journal of gastroenterology. Supplement.

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

H. Verspaget, S. Ganesh, Cornelis F. M. Sier, 1993, Gut.

Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells

H. Verspaget, C. Lamers, B. Hansen, 1993, Journal of Neuroimmunology.

Effects of CCK-8 and CCK-33 on human natural killer cell activity: studies on intestinal lamina propria and peripheral blood mononuclear cells.

H. Verspaget, C. Lamers, E. V. van Tol, 1993, Immunopharmacology.

Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro.

H. Verspaget, C. Lamers, A. Peña, 1991, Immunological investigations.

Intravenous administration of bombesin in man stimulates natural killer cell activity against tumour cells

H. Verspaget, A. Masclee, C. Lamers, 1991, Neuropeptides.

Neuropeptide regulation of cell-mediated cytotoxicity against human tumor cells

H. Verspaget, C. Lamers, E. Tol, 1990, Neuropeptides.

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.

H. Verspaget, G. Griffioen, J. Verheijen, 1987, Cancer research.

Plasminogen Activator Activity and Composition in Human Colorectal Carcinomas

H. Verspaget, G. Griffioen, J. Verheijen, 1987 .

Plasminogen Activators in the Intestine of Patients with Inflammatory Bowel Disease

H. Verspaget, J. Verheijen, G. Dooijewaard, 1988, Thrombosis and Haemostasis.

The IGF-matrilysin network in gastroenteropancreatic neuroendocrine tumours

C. Lamers, H. Verspaget, I. Biemond, 2011 .

Substance P receptor expression in patients with inflammatory bowel disease Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry

C. Lamers, M. V. D. Berg, I. Biemond, 2007, Neuropeptides.

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

H. Verspaget, F. Nagengast, S. Ganesh, 1995, British Journal of Cancer.

Chapter 6 Role of Matrix Metalloproteinase , Tissue Inhibitor of Metalloproteinase and Tumor Necrosis Factor-Single Nucleotide Gene Polymorphisms in Inflammatory Bowel Disease Short title : Role of SNPs in IBD

D. Hommes, H. Verspaget, C. Lamers, 2009 .

Impaired local natural killer cell activity in human colorectal carcinomas

H. Verspaget, C. Lamers, S. Peña, 2004, Cancer Immunology, Immunotherapy.

Detection of cells with NK activity from histologically normal mucosa in relation to disease.

H. Verspaget, C. Lamers, A. Peña, 1995, Advances in experimental medicine and biology.

Normal inflammatory bowel disease mucosa conceals alterations in natural killer cell activity.

H. Verspaget, C. Lamers, A. Peña, 1992, Scandinavian journal of gastroenterology.

The CD56 adhesion molecule is the major determinant for detecting non‐major histocompatibility complex‐restricted cytotoxic mononuclear cells from the intestinal lamina propria

H. Verspaget, C. Lamers, E. V. van Tol, 1992, European journal of immunology.

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.

D. Hommes, H. Verspaget, C. Lamers, 2007, World journal of gastroenterology.

Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study

C. Lamers, I. Biemond, C. Tang, 1996, Regulatory Peptides.

Chapter 2 M ucosal expression of bFGF , FGFR-1 and Syndecan-1 and their mRNA in Inflammatory Bowel Disease ( IBD ) Short title : bFGF complex in IBD

H. Verspaget, Q. Gao, H. Baelde, 2005 .

Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease

D. Hommes, H. Verspaget, C. Lamers, 2009, Inflammatory bowel diseases.

Chapter 7 Matrix Metalloproteinases and their Tissue Inhibitors as Prognostic Indicators for Diagnostic and Surgical Recurrence in Crohn ’ s Disease Short title : Recurrence in CD

D. Hommes, H. Verspaget, C. Lamers, 2009 .

Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison

H. Verspaget, C. Cornelisse, F. Bosman, 1992, Cancer.

Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum.

H. Verspaget, F. Bosman, G. Griffioen, 1991, Gastroenterology.

Value of Registration in the Identification and Surveillance of Familial Adenomatous Polyposis in the Netherlands

H. Verspaget, F. Nagengast, G. Griffioen, 1990 .

Mucin profiles and potential for malignancy of human colorectal adenomatous polyps

H. Verspaget, F. Bosman, G. Griffioen, 1989, Cancer.

Plasminogen activators in (pre)malignant conditions of the colorectum.

H. Verspaget, G. Griffioen, J. Verheijen, 1989, European journal of cancer & clinical oncology.

H. Verspaget, C. Lamers, R. A. Hogezand, 2001 .

H. Verspaget, C. Lamers, R. A. Hogezand, 2001, American Journal of Gastroenterology.

Crohn's disease of the upper gastrointestinal tract.

H. Verspaget, G. Griffioen, C. Lamers, 1997, The Netherlands journal of medicine.

Crohn's disease in the elderly: a comparison with young adults.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1998, Journal of clinical gastroenterology.

Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease

H. Verspaget, G. Griffioen, C. Lamers, 1995, Alimentary pharmacology & therapeutics.

Gastrin releasing peptide receptor expression is decreased in patients with Crohn’s disease but not in ulcerative colitis

C. Lamers, R. V. van Hogezand, I. Biemond, 2004, Journal of Clinical Pathology.

Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.

C. Lamers, G. Offerhaus, I. Biemond, 1997, British Journal of Cancer.

Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1996, Immunopharmacology.

Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

D. Hommes, H. Verspaget, J. Verheijen, 2009, Cancer science.

UvA-DARE ( Digital Academic Repository ) Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide

H. Verspaget, C. Lamers, R. Veenendaal, 1998 .

Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids

H. Verspaget, C. Lamers, B. Taal, 2011, Journal of endocrinological investigation.

Expression of peptide receptors in human endocrine tumours of the pancreas.

C. Lamers, I. Biemond, C. Tang, 1997, Gut.

Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

C. Bosman, C. V. D. van de Velde, H. Verspaget, 1998, British Journal of Cancer.

ASSESSMENT OF SERUM MATRIX METALLOPROTEINASES MMP-2 AND MMP-9 AFTER HUMAN LIVER TRANSPLANTATION: INCREASED SERUM MMP-9 LEVEL IN ACUTE REJECTION

J. Ringers, H. Verspaget, Q. Gao, 2004, Transplantation.

Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases.

A. Cats, B. Dijkmans, K. Havenga, 1992, British journal of rheumatology.

Plasma MMP–2 and MMP–9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation

H. Verspaget, C. Legnani, G. Palareti, 2004, Thrombosis and Haemostasis.

Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine

C. Lamers, M. Meijer, I. Biemond, 2008, Inflammatory bowel diseases.

Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.

H. Verspaget, S. Ganesh, Cornelis F. M. Sier, 1995, European journal of cancer.

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

H. Verspaget, G. Griffioen, J. Verheijen, 1989, British Journal of Cancer.

Crohn's disease of the upper gastrointestinal tract: the value of endoscopic examination.

H. Verspaget, C. Lamers, R. Veenendaal, 1998, Scandinavian journal of gastroenterology. Supplement.

IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer.

C. Lamers, R. Veenendaal, A. Peña, 1992, Scandinavian journal of gastroenterology.

Upper gastrointestinal manifestations in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis?

B. Dijkmans, C. Lamers, M. Janssen, 1990, Scandinavian journal of gastroenterology. Supplement.

Faecal parameters in the assessment of activity in inflammatory bowel disease.

H. Verspaget, C. Lamers, A. van der Sluys Veer, 1999, Scandinavian journal of gastroenterology. Supplement.

Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vitro analysis.

H. Verspaget, C. Lamers, A. Peña, 1991, Scandinavian journal of gastroenterology.

Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies.

C. Lamers, R. Veenendaal, A. Peña, 1995, Journal of clinical pathology.

Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors.

C. Lamers, B. Taal, J. Bonfrer, 2004, Clinical chemistry.

Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1997, The American journal of gastroenterology.

Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.

H. Verspaget, F. Kubben, G. Griffioen, 2007, European journal of cancer.

Impaired activation of the neutrophil oxidative metabolism in chronic inflammatory bowel disease.

H. Verspaget, C. Lamers, A. Peña, 1986, Scandinavian journal of gastroenterology.

Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectum

C. Fellbaum, H. Verspaget, M. Schmitt, 1991, Histopathology.

Isolation, characterization, and determination of human liver (copper/zinc) metallothionein

H. Verspaget, C. Lamers, A. Janssens, 1990, Experientia.

Practical Management of Hepatocellular Carcinoma

C. Lamers, B. Hoek, C. Lamers, 2001, Scandinavian journal of gastroenterology. Supplement.

Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease

H. Verspaget, G. Griffioen, C. Lamers, 1993, Alimentary pharmacology & therapeutics.

Risk factors of peptic ulcer disease: Different impact of Helicobacter pylori in Dutch and Japanese populations?

J. Vandenbroucke, C. Lamers, R. Schlemper, 1996, Journal of gastroenterology and hepatology.

Cholecystokinin receptors in human pancreas and gallbladder muscle: A comparative study

C. Lamers, I. Biemond, C. Lamers, 1996, Regulatory Peptides.

Contribution of plasma cortisol to corticosteroid-suppressed peripheral blood natural killer cell activity in Crohn's disease.

H. Verspaget, G. Griffioen, C. Lamers, 1995, Immunopharmacology.

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

H. Verspaget, C. Lamers, A. Peña, 1988, Gut.

Identification of Neurotensin Binding Sites: Neurotensin receptor-1 and -3 are Expressed in the Human Gastrointestinal Tract

C. Lamers, M. V. D. Berg, I. Biemond, 2008 .

Is radiolabelled sucralphate scintigraphy of any use in the diagnosis of inflammatory bowel disease?

H. Verspaget, E. Pauwels, C. Lamers, 1988, Nuclear medicine communications.

Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.

H. Verspaget, E. Pauwels, C. Lamers, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.

Valérie Ferreira, Hein W Verspaget, D. Hommes, 2008, European journal of cancer.

Diagnosis of Crohn's Ileitis and Monitoring of Disease Activity: Value of Doppler Ultrasound of Superior Mesenteric Artery Flow

G. Griffioen, C. Lamers, M. Wasser, 1998, American Journal of Gastroenterology.

Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study

E. Kuipers, J. Kleibeuker, C. Lamers, 1999, Gut.

Campylobacter jejuni peritonitis in a patient with liver cirrhosis.

C. Lamers, B. van Hoek, R. Veenendaal, 1996, European journal of gastroenterology & hepatology.

Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation.

H. Verspaget, E. Pauwels, C. Lamers, 1988, Digestion.

Image quality and radiopharmaceutical parameters of Indium-111 granulocytes in scintigraphy of inflammatory bowel disease

H. Verspaget, E. Pauwels, C. Lamers, 2004, European Journal of Nuclear Medicine.

Value of indium-111 tropolonate autologous granulocyte scintigraphy in the assessment of inflammatory bowel disease.

H. Verspaget, E. Pauwels, C. Lamers, 1990, Scandinavian journal of gastroenterology. Supplement.

A Prospective Comparison of 99mTc-Labeled Polyclonal Human Immunoglobulin and 111In Granulocytes for Localization of Inflammatory Bowel Disease

H. Verspaget, E. Pauwels, G. Griffioen, 1992, Acta radiologica.

Technetium-99m nanocolloid for the scintigraphic assessment of inflammatory bowel disease in the colon: its value in comparison with indium-111-labelled granulocytes.

H. Verspaget, E. Pauwels, G. Griffioen, 1991, European journal of radiology.

Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy

H. Leufkens, E. Heerdink, C. Lamers, 2001, Pharmacy World and Science.

Serum pepsinogens after interruption of long-term maintenance therapy with omeprazole in patients with reflux esophagitis

C. Lamers, S. Meuwissen, I. Biemond, 1993, Digestive Diseases and Sciences.

Expression of receptors for gut peptides in pancreata of BOP-treated and control hamsters

R. Woutersen, C. Lamers, M. Appel, 1996, Regulatory Peptides.

Expression of somatostatin receptors in human pancreatic tumor.

H. Verspaget, C. Lamers, G. Offerhaus, 1998, Pancreas.

Gut peptide receptors in pancreata of azaserine-treated and normal control rats.

R. Woutersen, C. Lamers, M. Appel, 1995, Carcinogenesis.

Localization and quantification of cholecystokinin receptors in rat brain with storage phosphor autoradiography.

C. Lamers, I. Biemond, C. Tang, 1995, BioTechniques.

Preclinical Detection of Familial Adenomatous Polyposis: Fact or Fancy?

H. Verspaget, G. Griffioen, C. Lamers, 1989 .

Liver chimerism after allogeneic blood stem cell transplantation.

H. Verspaget, C. Lamers, B. van Hoek, 2007, Transplantation proceedings.

Proximal Crohn's Disease: Review of the Clinicopathologic Features and Therapy

C. Lamers, R. Veenendaal, R. V. van Hogezand, 2001, Inflammatory bowel diseases.

Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?

H. Verspaget, E. Pauwels, C. Lamers, 1989, Gut.

Expression of HLA-DQ antigens in the small-intestinal mucosa of patients with coeliac disease.

M. Mearin, R. Bontrop, J. Schweizer, 1991, Scandinavian journal of gastroenterology.

Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects.

C. Lamers, J. Lindeman, I. Biemond, 1994, Journal of clinical pathology.

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)‐2 and ‐9 in Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2007, Inflammatory bowel diseases.

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

C. V. D. van de Velde, H. Verspaget, S. Ganesh, 1997, British Journal of Cancer.

Hepatic vein stenting for Budd-Chiari syndrome.

C. Lamers, B. van Hoek, R. Veenendaal, 1997, The American journal of gastroenterology.

Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.

J. Ringers, H. Verspaget, C. Lamers, 2003, Transplantation proceedings.

Endoglin shedding in colorectal cancer

D. Hommes, H. Verspaget, P. Dijke, 2009 .

A case of recurrent gastrinoma in the liver with a review of “primary” hepatic gastrinomas

H. Verspaget, C. Lamers, I. Biemond, 2009, BMJ Case Reports.

Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract.

H. Verspaget, C. Lamers, A. Peña, 1991, Journal of clinical & laboratory immunology.

Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID use.

B. Dijkmans, J. Vandenbroucke, A. Zwinderman, 1995, Scandinavian journal of rheumatology.

Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer.

H. Verspaget, C. Lamers, A. Janssens, 1992, Journal of hepatology.

Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.

H. Verspaget, G. Griffioen, C. Lamers, 1998, Scandinavian journal of gastroenterology. Supplement.

The 13carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting

C. Lamers, S. V. van Eeden, G. Offerhaus, 2006, Alimentary pharmacology & therapeutics.

Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens.

C. V. van Boven, H. Endtz, C. Lamers, 1993, Journal of clinical pathology.

Effect of the anti‐tumor necrosis factor‐&agr; antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

H. Verspaget, J. Verheijen, C. Lamers, 2007, Inflammatory bowel diseases.

5-HIAAA in patients with carcinoid tumours

C. Lamers, B. Taal, J. Bonfrer, 2007 .

Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidants

H. Verspaget, C. Lamers, L. Kruidenier, 2003, The Journal of pathology.

Chapter 3 Effect of the Anti-Tumor Necrosis Factor-Antibody Infliximab on the ex vivo Mucosal Matrix Metalloproteinase-Proteolytic Phenotype in Inflammatory Bowel Disease ( IBD ) Short title : Infliximab and MMPs in IBD

H. Verspaget, J. Verheijen, C. Lamers, 2009 .

5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.

P. Devilee, D. Hommes, H. Verspaget, 2009, Carcinogenesis.

Campylobacter pylori: prevalence and significance in patients with chronic renal failure.

C. Lamers, G. Offerhaus, R. Valentijn, 1989, Clinical nephrology.

Long term serological surveillance after treatment of Helicobacter pylori infection.

H. Endtz, C. Lamers, R. Veenendaal, 1991, Gut.

Diagnostic Efficacy of the Secretin Stimulation Test for the Zollinger-Ellison Syndrome: An Intra-Individual Comparison Using Different Dosages in Patients and Controls

H. Verspaget, A. Masclee, C. Lamers, 2010, Pancreatology.

Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).

H. Morreau, N. Gruis, W. Bergman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Leucocyte matrix metalloproteinase (MMP)-9 gene and protein regulation in Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2003 .

Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma

H. Verspaget, J. Verheijen, C. Lamers, 2003, Thrombosis and Haemostasis.

Determinants of Headache in Lansoprazole Users in The Netherlands

H. Leufkens, E. Heerdink, C. Lamers, 2002, Drug safety.

Chapter 3 Liver chimerism after allogeneic blood stem cell transplantation

Bart, H. Verspaget, C. Lamers, 2011 .

Mucosal gelatinases MMP-2 and MMP-9 in Helicobacter pylori-associated gastritis

H. Verspaget, F. Kubben, J. Verheijen, 2007 .

Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer 1

Cornelis J H van de Velde, Hein W Verspaget, C. V. D. van de Velde, 2002 .

Metallothionein in human gastrointestinal cancer

C. V. D. van de Velde, H. Verspaget, G. Griffioen, 2000, The Journal of pathology.

NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis.

B. Dijkmans, J. Vandenbroucke, C. Lamers, 1995, Scandinavian journal of gastroenterology. Supplement.

The expression of receptors for vasoactive intestinal peptide and secretin in colon neoplasms

H. Verspaget, C. Lamers, Chengwei Tang, 2001 .

Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors.

C. Lamers, R. Veenendaal, I. Biemond, 1992, Gut.

Mucosal inflammation and disease in Helicobacter pylori infection.

C. Lamers, R. Veenendaal, J. M. Götz, 1996, Scandinavian journal of gastroenterology. Supplement.

Serum gastrin and mucosal somatostatin in Helicobacter pylori-associated gastritis.

C. Lamers, R. Veenendaal, I. Biemond, 1995, Scandinavian journal of gastroenterology.

Natural killer cell activity in patients with neuroendocrine tumours of the gastrointestinal tract; Relation with circulating gastrointestinal hormones

H. Verspaget, C. Lamers, A. Peña, 1991, Neuropeptides.

Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association.

J. Vandenbroucke, C. Lamers, R. Schlemper, 1995, Archives of internal medicine.

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.

H. Verspaget, C. Lamers, R. V. van Hogezand, 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Serological parameters in assessment of degree of gastritis in healthy volunteers

C. Lamers, J. Lindeman, I. Biemond, 1995, Digestive Diseases and Sciences.

A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients.

B. Dijkmans, J. Vandenbroucke, A. Zwinderman, 1994, British journal of rheumatology.

Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease

C. Lamers, R. Schlemper, I. Biemond, 1996, European journal of gastroenterology & hepatology.

Matrix metalloproteinases in inflammatory bowel disease

H. Verspaget, C. Lamers, M. Meijer, 2000 .

Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori.

C. Lamers, R. Veenendaal, S. Bernards, 1995, Scandinavian journal of gastroenterology. Supplement.

Superoxide dismutases in the human colorectal cancer sequence

C. V. D. van de Velde, G. Griffioen, C. Lamers, 1999, Journal of Cancer Research and Clinical Oncology.

Monitoring response during a randomised controlled trial of escalating interferon dose for chronic hepatitis C infection: predictive value of quantitative and qualitative HCV RNA assays.

C. Lamers, B. van Hoek, J. Schinkel, 2001, Journal of Clinical Virology.

Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.

H. Verspaget, C. Lamers, A. Peña, 1988, Gut.

Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2004, Alimentary pharmacology & therapeutics.

Differences in the immunoglobulin synthesis by peripheral blood lymphocytes in Crohn's disease and ulcerative colitis.

H. Verspaget, C. Lamers, A. Peña, 1987, Digestion.

Local Immunoglobulin A Subclass Alteration in the Gastric Mucosa of Helicobacter pylori -Infected Patients

C. Lamers, R. Veenendaal, A. Peña, 1993 .

Development of a radioimmunoassay for human metallothionein.

H. Verspaget, C. Lamers, A. Janssens, 1990, Journal of immunological methods.

A new deletion polymorphism at D5S71 raises the linkage information on adenomatous polyposis coli: implications for presymptomatic diagnosis

F. Nagengast, G. Griffioen, C. Lamers, 1991, Human Genetics.

Linkage Studies on Familial Adenomatous Polyposis in the Netherlands

G. Griffioen, C. Lamers, H. Vasen, 1990 .

Achlorhydria does not protect against benign upper gastrointestinal ulcers during NSAID use

B. Dijkmans, J. Vandenbroucke, C. Lamers, 1994, Digestive Diseases and Sciences.

Surveillance for familial pancreatic cancer.

H. Morreau, C. Lamers, H. Vasen, 2003, Scandinavian journal of gastroenterology. Supplement.

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

P. Quax, H. Verspaget, S. Ganesh, 1993, Invasion & metastasis.

In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.

H. Verspaget, C. Lamers, A. Peña, 1989, Journal of clinical & laboratory immunology.

No effect of intramuscular gold therapy on serological parameters of Helicobacter pylori infection in patients with rheumatoid arthritis: a 12 month prospective study.

B. Dijkmans, J. Hermans, C. Lamers, 1994, Annals of the Rheumatic Diseases.

Clinical aspects of small-bowel transplantation.

J. Ringers, C. Lamers, B. van Hoek, 2000, Scandinavian journal of gastroenterology. Supplement.

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

R. Westendorp, P. Kluin, C. Lamers, 1995, Gut.

Multiple endocrine neoplasia syndromes.

C. Lamers, H. Vasen, C. Lips, 1984, Critical reviews in oncology/hematology.

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

J. Kleibeuker, Lamers, C. Lamers, 1999, Alimentary pharmacology & therapeutics.

Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs.

H. Verspaget, G. Griffioen, C. Lamers, 2000, Scandinavian Journal of Gastroenterology, Supplement.

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

D. Jewell, P. Rutgeerts, Å. Danielsson, 1996, Gut.

Circulating cell death products predict clinical outcome of colorectal cancer patients

D. Hommes, H. Verspaget, C. Lamers, 2009, BMC Cancer.

The changing role of H2-receptor antagonists in acid-related diseases

C. Lamers, 1996, European Journal of Gastroenterology and Hepathology.

A comparison of budesonide with prednisolone for active Crohn's disease.

D. Jewell, P. Rutgeerts, P. Rutgeerts, 1994, The New England journal of medicine.

Prognostic significance of metallothionein in human gastrointestinal cancer.

H. Verspaget, F. Kubben, G. Griffioen, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Activity of Crohn's disease assessed by measurement of superior mesenteric artery flow with Doppler ultrasound.

A. Roos, A. de Roos, G. Griffioen, 1998, The Netherlands journal of medicine.

Diagnostic Efficacy of the Secretin Stimulation Test for the Zollinger-Ellison Syndrome: An Intra-Individual Comparison Using Different Dosages in Patients and Controls

H. Verspaget, A. Masclee, C. Lamers, 2010, Pancreatology (Print).

Flexible Limited Sampling Model for Monitoring Tacrolimus in Stable Patients Having Undergone Liver Transplantation With Samples 4 to 6 Hours After Dosing Is Superior to Trough Concentration

D. Hommes, C. Lamers, J. Hartigh, 2008, Therapeutic drug monitoring.

Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine

C. Lamers, M. Meijer, I. Biemond, 2008, Inflammatory bowel diseases.